Have a personal or library account? Click to login
Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study Cover

Comparative Evaluation of BGR-34 and Sitagliptin in Diabetic Subjects - Open Labelled Randomised Parallel Clinical Study

EABR. Experimental and Applied Biomedical Research
Volume 22 (2021): Issue 4 (December 2021)
By: Ravinder Singh,  Harbir Kaur Rao,  Anil Sharma,  Thakur Gurjeet Singh,  Abhimanyu Parashar,  Randhir Singh and  Balraj Saini  
Open Access
|Feb 2022
DOI: https://doi.org/10.2478/sjecr-2021-0057 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 325 - 332
Submitted on: Oct 5, 2020
|
Accepted on: Mar 6, 2021
|
Published on: Feb 2, 2022
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
diabetes mellitus,
blood glucose regulator-34,
DPP-4 inhibitors,
hyperglycemia,
sitagliptin
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2022 Ravinder Singh, Harbir Kaur Rao, Anil Sharma, Thakur Gurjeet Singh, Abhimanyu Parashar, Randhir Singh, Balraj Saini, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 22 (2021): Issue 4 (December 2021)Next article